Is LT7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6
Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of LT7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: LT7 (€19.4) is trading below our estimate of fair value (€50.4)
Significantly Below Fair Value: LT7 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for LT7?
Key metric: As LT7 is an unprofitable bank we use its Price-To-Book Ratio for relative valuation analysis.
The above table shows the Price to Book ratio for LT7. This is calculated by dividing LT7's market cap by their current
book value.
What is LT7's PB Ratio?
PB Ratio
0.5x
Book
CA$2.67b
Market Cap
CA$1.29b
LT7 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Book vs Industry: LT7 is good value based on its Price-To-Book Ratio (0.5x) compared to the European Banks industry average (0.8x).
Price to Book Ratio vs Fair Ratio
What is LT7's PB Ratio
compared to its
Fair PB Ratio?
This is the expected PB Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
LT7 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio
0.5x
Fair PB Ratio
n/a
Price-To-Book vs Fair Ratio: Insufficient data to calculate LT7's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst LT7 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€19.40
€19.00
-2.1%
6.9%
€21.04
€16.96
n/a
9
Nov ’25
€16.80
€17.59
+4.7%
6.1%
€19.17
€15.21
n/a
10
Oct ’25
€18.40
€17.59
-4.4%
5.4%
€18.73
€15.39
n/a
10
Sep ’25
€17.60
€17.59
-0.06%
4.5%
€18.80
€16.11
n/a
10
Aug ’25
€17.50
€18.00
+2.9%
9.6%
€22.25
€16.18
n/a
10
Jul ’25
€18.60
€18.00
-3.2%
9.6%
€22.25
€16.18
n/a
10
Jun ’25
€17.60
€18.78
+6.7%
9.0%
€22.28
€17.55
n/a
11
May ’25
€17.20
€18.54
+7.8%
10.1%
€22.36
€16.26
n/a
11
Apr ’25
€18.90
€18.54
-1.9%
10.1%
€22.36
€16.26
n/a
11
Mar ’25
€17.50
€18.69
+6.8%
10.0%
€22.46
€16.33
n/a
11
Feb ’25
€17.80
€20.03
+12.5%
7.9%
€22.56
€17.77
n/a
10
Jan ’25
€18.30
€19.71
+7.7%
8.9%
€22.57
€17.78
n/a
11
Dec ’24
€17.00
€21.11
+24.2%
14.2%
€28.82
€18.10
n/a
10
Nov ’24
€16.90
€24.66
+45.9%
11.5%
€29.91
€18.78
€16.80
11
Oct ’24
€21.00
€25.77
+22.7%
11.0%
€31.34
€22.29
€18.40
11
Sep ’24
€24.80
€28.30
+14.1%
11.2%
€36.85
€24.57
€17.60
13
Aug ’24
€27.00
€29.22
+8.2%
17.7%
€40.77
€23.10
€17.50
13
Jul ’24
€22.80
€26.96
+18.2%
14.8%
€38.26
€22.96
€18.60
12
Jun ’24
€20.80
€26.53
+27.5%
15.1%
€37.82
€22.00
€17.60
12
May ’24
€21.00
€27.71
+31.9%
13.6%
€37.94
€22.76
€17.20
12
Apr ’24
€21.40
€27.71
+29.5%
13.6%
€37.94
€22.76
€18.90
12
Mar ’24
€23.40
€27.71
+18.4%
13.6%
€37.94
€22.76
€17.50
12
Feb ’24
€24.20
€27.84
+15.0%
14.1%
€38.04
€22.83
€17.80
12
Jan ’24
€22.60
€27.84
+23.2%
14.1%
€38.04
€22.83
€18.30
12
Dec ’23
€23.40
€29.55
+26.3%
13.5%
€38.46
€23.95
€17.00
11
Nov ’23
€22.20
€33.01
+48.7%
10.3%
€40.35
€29.69
€16.90
11
Analyst Forecast: Target price is lower than the current share price.